154 related articles for article (PubMed ID: 26189249)
21. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
22. MET is a predictive factor for late recurrence but not for overall survival of early stage hepatocellular carcinoma.
Koh YW; Park YS; Kang HJ; Shim JH; Yu E
Tumour Biol; 2015 Jul; 36(7):4993-5000. PubMed ID: 25874493
[TBL] [Abstract][Full Text] [Related]
23. Rap1GAP inhibits tumor progression in endometrial cancer.
Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
[TBL] [Abstract][Full Text] [Related]
24. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
[TBL] [Abstract][Full Text] [Related]
25. Associations between lymphovascular space invasion, nodal recurrence, and survival in patients with surgical stage I endometrioid endometrial adenocarcinoma.
Veade AE; Foote J; Ehrisman J; Broadwater G; Davidson BA; Lee PS; Secord AA; Berchuck A; Havrilesky LJ
World J Surg Oncol; 2019 May; 17(1):80. PubMed ID: 31077193
[TBL] [Abstract][Full Text] [Related]
26. Expression of the recepteur d'originenantais receptor tyrosine kinase in non-small cell lung cancer and its clinical significance.
Han WL; Li WD; Hu J; Rusidanmu A; Chen LF; Shen L; Zheng SS
Chin Med J (Engl); 2012 Mar; 125(6):1110-4. PubMed ID: 22613539
[TBL] [Abstract][Full Text] [Related]
27. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
28. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
29. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
30. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
31. Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder.
Cheng HL; Liu HS; Lin YJ; Chen HH; Hsu PY; Chang TY; Ho CL; Tzai TS; Chow NH
Br J Cancer; 2005 May; 92(10):1906-14. PubMed ID: 15870710
[TBL] [Abstract][Full Text] [Related]
32. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of LncRNA FER1L4 in endometrial carcinoma is associated with favorable survival outcome.
Kong Y; Ren Z
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8113-8118. PubMed ID: 30556848
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
Steinbakk A; Malpica A; Slewa A; Skaland I; Gudlaugsson E; Janssen EA; Løvslett K; Fiane B; Kruse AJ; Feng W; Yinhua Y; Baak JP
Mod Pathol; 2011 Sep; 24(9):1262-71. PubMed ID: 21552210
[TBL] [Abstract][Full Text] [Related]
35. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
36. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors].
Fracchioli S; Katsaros D; Maggiora P; Di Renzo MF; Massobrio M
Minerva Ginecol; 1999 Oct; 51(10):359-64. PubMed ID: 10638160
[TBL] [Abstract][Full Text] [Related]
38. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
39. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
[TBL] [Abstract][Full Text] [Related]
40. Ezrin expression is related to poor prognosis in FIGO stage I endometrioid carcinomas.
Köbel M; Langhammer T; Hüttelmaier S; Schmitt WD; Kriese K; Dittmer J; Strauss HG; Thomssen C; Hauptmann S
Mod Pathol; 2006 Apr; 19(4):581-7. PubMed ID: 16554733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]